3.7. MBP-11901 Induced Anticancer Effects on HCC through Inhibition of Multitarget Tyrosine Kinase, FLT3, VEGFR2, PDGFRβ, and c-KIT. The gene discussed is PDGFRB; the disease is hepatocellular carcinoma.